THE LATEST NEWS, DEVELOPMENTS AND ANNOUNCEMENTS AS THEY HAPPEN
CONFERENCES, TRADE SHOWS, LIVE WEBCASTS, NEW LAUNCHES, SEMINARS AND TRAINING EVENTS
PARTNERS, SOLUTIONS & SERVICE PROVIDERS, SUPPLIERS AND INDUSTRY ORGANIZATIONS
WHITEPAPERS, MARKET REPORTS, RESEARCH, ON-DEMAND WEBINARS, VIDEOS AND INFOGRAPHICS
AstraZeneca has announced a collaboration with US biotech AVEO oncology to investigate a potential cancer immunotherapy combination in liver cancer. AZ’s Imfinzi (durvalumab) immunotherapy has s...
Shares in Neurocrine Biosciences slumped by as much as a fifth after a much-anticipated trial in Tourette’s syndrome missed the mark. The phase IIb T-Force GOLD study of valbenazine showed that ...
A large head-to-head study has shown Johnson & Johnson’s psoriasis drug Tremfya outperformed Novartis’ rival, Cosentyx, which had previously set standards in moderate to severe disease...
NICE has rejected two pioneering drugs for the rare inherited condition, hereditary transthyretin-related amyloidosis (hATTR) in the first draft guidance. The cost-effectiveness body had been using an...
Seasonal influenza vaccines are typically less than 50 percent effective, according to Centers for Disease Control and Prevention studies. Research at the University of Alabama at Birmingham, publishe...
Immunotherapy has proved effective in treating a number of cancers, but brain tumors have remained stubbornly resistant. Now, a new study suggests that a slow-growing brain tumor arising in patients a...
Many people who are diagnosed with cancer will undergo some type of surgery to treat their disease — almost 95 percent of people with early-diagnosed breast cancer will require surgery and it&rs...
In cancer patients, there can be tremendous variation in the types of cancer cells from one patient to another, even within the same disease. Identification of the particular cell types present can be...
Contego Medical, based in Raleigh, North Carolina, landed FDA clearance for its Vanguard IEP peripheral balloon angioplasty system. The product features the Congego’s proprietary Integrated Embo...
Perhaps unsurprisingly, one of the major world events that happened in 2016 was the UK referendum in June 2016 on whether to leave the EU. In the lead up to the vote, we published a head to head piece...
This year was a big year for Clinical Pharmacist, which started with its relaunch in January as a peer-reviewed journal and it being sent to all members of the Royal Pharmaceutical Society as part of ...
On 7 December 2016 the Competition and Markets Authority (“CMA”) took an infringement decision, resulting in the fining of pharmaceutical company Pfizer and distributor Flynn Pharma. The companies wer...
Two years ago, the leading German pharmaceutical company, Boehringer Ingelheim, applied to Slovak authorities for its new anti-diabetes drug, Synjardy, to be covered by health insurance. Drug manufac...
Herbert Smith Freehills (HSF) and Latham & Watkins won lead roles on Baxter International's acquisition of Claris Injectables for $625m, in a bid by Baxter to expand its portfolio of essential generic...
For FDA professionals focused on drug quality and safety, the rapid increase in imported drugs from nations where we devote limited inspection resources is of great concern. One way to address this co...
We all know someone who has been given the diagnosis of cancer. It is definitely life-changing. The first time I was effected by the diagnosis was when my father received it. I didn’t think to ask him...
Industry experts say the Obama administration's decision to lift a ban on importing Cuban pharmaceuticals and collaborating with the nation's researchers could bring the nation's cheaper, reputable me...
Digital health tech is moving beyond the consumer market. Research from Frost & Sullivan shows that the healthcare wearables device market could more than triple to $18.9 billion in 2020 from $5.1 bil...